R&D The role of the opioid pathway in schizophrenia and bipolar ... Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.
R&D Sponsored Advancing RSV and hMPV research through human challenge tria... Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.
R&D Sponsored Best practices in cardiometabolic trial design: Planning and... Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.
R&D Whole-genome sequencing in the UK and Europe, with Mark Robi... Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
R&D AMR and vaccines: Can universal coverage avert a post-antibi... Antimicrobial resistance (AMR) is a growing global health crisis.
R&D Treating the chronic diseases GLP-1s miss, with Laurent Auda... Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
News ESMO26: Lily's sofe-m ADC stakes a claim in ovarian cancer Eli Lilly's first major readout at ESMO comes from a phase 1 trial of its FRα-targeting sofe-m in platinum-sensitive ovarian cancer (PSOC).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
